{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:31Z","timestamp":1782602551544,"version":"3.54.5"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.4710","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T05:35:05Z","timestamp":1452836105000},"page":"185-190","source":"Crossref","is-referenced-by-count":41,"title":["Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome"],"prefix":"10.2169","volume":"55","author":[{"given":"Yusuke","family":"Yamaga","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonobu","family":"Tokuyama","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Murayama","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Yamakita","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshige","family":"Kunieda","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Matsunami General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki (Japanese Journal of Clinical Hematology) 51: 320-325, 2010 (in Japanese, Abstract in English)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Inoue M, Ankou M, Hua J, Iwaki Y, Hagihara M, Ota Y. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporine A: a case report. J Clin Exp Hematop 53: 95-99, 2013.","DOI":"10.3960\/jslrt.53.95"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Iwaki N, Sato Y, Takata K, et al. Atypical hyaline vascular-type Castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy. J Clin Exp Hematop 53: 87-93, 2013.","DOI":"10.3960\/jslrt.53.87"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kawabata H, Kotani S, Matsumura Y, et al. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Intern Med 52: 1503-1507, 2013.","DOI":"10.2169\/internalmedicine.52.9482"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Masaki Y, Nakajima A, Iwao H, et al. Japanese variant of multicentric Castleman's disease associated with serositis and thrombocytopenia: a report of two cases: is TAFRO syndrome (Castleman-Kojima Disease) a distinct clinicopathological entity? J Clin Exp Hematop 53: 79-85, 2013.","DOI":"10.3960\/jslrt.53.79"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kojima M, Nakamura S, Nishikawa M, Itoh H, Miyawaki S, Masawa N. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases. Pathol Res Pract 201: 325-332, 2005.","DOI":"10.1016\/j.prp.2005.01.006"},{"key":"7","unstructured":"7. Van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol 8: 486-498, 2010."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cesaman E, Knowles DM. The role of Kaposi's sarcoma-associated herpes virus (KSHV\/HHV-8) in lymphoproliferative diseases. Semin Cancer Biol 9: 165-174, 1999.","DOI":"10.1006\/scbi.1998.0118"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implications of idiopathic multicentric Castleman disease among Japanese: a report of 28 cases. Int J Surg Pathol 16: 391-398, 2008.","DOI":"10.1177\/1066896908315812"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kojima M, Nakamura N, Tsukamoto N, et al. Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus 20: 44-50, 2011.","DOI":"10.1177\/0961203310381510"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.","DOI":"10.1002\/art.1780251101"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kubokawa I, Yachie A, Hayakawa A, et al. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease. BMC Pediatr 14: 139, 2014.","DOI":"10.1186\/1471-2431-14-139"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/2\/55_55.4710\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:47:28Z","timestamp":1498276048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/2\/55_55.4710\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.4710","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}